
The Medical Equipment industry is up 2.8% in the last week, with Shanghai MicroPort MedBot (Group) up 27%. During this same period, the Hangzhou Diagens Biotechnology underperformed, falling 5.4%. This means that the industry has gained 39% over the past year. Looking forward, earnings are forecast to grow by 51% annually.
Has the Hong Kong Medical Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Apr 2026 | HK$257.6b | HK$66.1b | HK$2.5b | 16.5x | 103.2x | 3.9x |
| Sun, 15 Mar 2026 | HK$223.8b | HK$64.0b | HK$2.4b | 16.4x | 93.8x | 3.5x |
| Tue, 10 Feb 2026 | HK$240.0b | HK$63.6b | HK$2.3b | 18.5x | 102.4x | 3.8x |
| Thu, 08 Jan 2026 | HK$233.8b | HK$62.9b | HK$2.3b | 20.8x | 101.3x | 3.7x |
| Sat, 06 Dec 2025 | HK$215.0b | HK$63.4b | HK$3.1b | 19.2x | 69.4x | 3.4x |
| Mon, 03 Nov 2025 | HK$223.4b | HK$63.0b | HK$3.1b | 20.6x | 72.8x | 3.5x |
| Wed, 01 Oct 2025 | HK$227.4b | HK$62.9b | HK$3.0b | 20.9x | 76.6x | 3.6x |
| Fri, 29 Aug 2025 | HK$216.5b | HK$62.8b | HK$3.4b | 19.5x | 63.1x | 3.4x |
| Sun, 27 Jul 2025 | HK$214.6b | HK$62.0b | HK$3.2b | 20.9x | 66.5x | 3.5x |
| Tue, 24 Jun 2025 | HK$180.8b | HK$61.9b | HK$3.2b | 21.8x | 56.2x | 2.9x |
| Thu, 22 May 2025 | HK$168.5b | HK$61.7b | HK$3.2b | 21.9x | 52.7x | 2.7x |
| Sat, 19 Apr 2025 | HK$152.0b | HK$60.7b | HK$3.1b | 20.6x | 48.7x | 2.5x |
| Mon, 17 Mar 2025 | HK$171.1b | HK$58.6b | HK$577.8m | 21.6x | 296.1x | 2.9x |
| Wed, 12 Feb 2025 | HK$151.0b | HK$57.9b | HK$1.2b | 18.4x | 128.5x | 2.6x |
| Fri, 10 Jan 2025 | HK$130.5b | HK$57.7b | HK$1.2b | 18.1x | 112.3x | 2.3x |
| Sun, 08 Dec 2024 | HK$133.0b | HK$58.0b | HK$1.2b | 15.2x | 111.6x | 2.3x |
| Tue, 05 Nov 2024 | HK$137.2b | HK$59.0b | HK$1.3b | 15.7x | 106.9x | 2.3x |
| Thu, 03 Oct 2024 | HK$149.2b | HK$59.6b | HK$1.4b | 14.1x | 106.4x | 2.5x |
| Sat, 31 Aug 2024 | HK$120.3b | HK$58.5b | HK$812.5m | 11.9x | 148x | 2.1x |
| Mon, 29 Jul 2024 | HK$118.2b | HK$54.0b | -HK$1,093,747,374.92 | 12.5x | -108.1x | 2.2x |
| Wed, 26 Jun 2024 | HK$124.8b | HK$53.9b | -HK$1,096,788,549.10 | 12.6x | -113.8x | 2.3x |
| Fri, 24 May 2024 | HK$150.2b | HK$54.1b | -HK$1,091,423,073.75 | 15.6x | -137.6x | 2.8x |
| Sun, 21 Apr 2024 | HK$138.7b | HK$54.2b | -HK$1,095,684,295.95 | 13.4x | -126.6x | 2.6x |
| Tue, 19 Mar 2024 | HK$157.2b | HK$52.7b | -HK$1,043,399,988.96 | 12.1x | -150.6x | 3x |
| Thu, 15 Feb 2024 | HK$151.5b | HK$53.3b | -HK$2,426,868,822.95 | 11.8x | -62.4x | 2.8x |
| Sat, 13 Jan 2024 | HK$182.7b | HK$53.6b | -HK$2,350,584,822.00 | 14.1x | -77.7x | 3.4x |
| Mon, 11 Dec 2023 | HK$195.2b | HK$53.5b | -HK$2,343,144,300.00 | 15.3x | -83.3x | 3.6x |
| Wed, 08 Nov 2023 | HK$216.2b | HK$53.0b | -HK$2,340,360,865.00 | 18.1x | -92.4x | 4.1x |
| Fri, 06 Oct 2023 | HK$209.2b | HK$52.9b | -HK$2,345,249,350.00 | 20.2x | -89.2x | 4x |
| Sun, 03 Sep 2023 | HK$218.6b | HK$53.2b | -HK$2,352,088,097.00 | 17x | -92.9x | 4.1x |
| Tue, 01 Aug 2023 | HK$252.2b | HK$51.2b | -HK$3,934,611,428.00 | 20.2x | -64.1x | 4.9x |
| Thu, 29 Jun 2023 | HK$239.9b | HK$50.9b | -HK$3,939,953,613.00 | 19.6x | -60.9x | 4.7x |
| Sat, 27 May 2023 | HK$259.8b | HK$51.8b | -HK$3,964,052,691.00 | 20.5x | -65.6x | 5x |
| Mon, 24 Apr 2023 | HK$302.3b | HK$53.1b | -HK$4,232,098,730.00 | 22.8x | -71.4x | 5.7x |
-71.4x
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.64% | |
| Healthcare | 3.68% | |
| Medical Equipment | 4.81% | |
| Medical Equipment | 5.72% | |
| Medical Supplies | 1.93% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2252 Shanghai MicroPort MedBot (Group) | HK$34.68 | 26.8% +HK$7.6b | 123.5% | PS56.6x | |
| 6699 Angelalign Technology | HK$90.85 | 10.9% +HK$1.5b | 94.1% | PE69.8x | |
| 853 MicroPort Scientific | HK$9.58 | 6.0% +HK$1.0b | 45.6% | PS2.4x | |
| 2276 Shanghai Conant Optical | HK$46.80 | 4.3% +HK$973.3m | 106.6% | PE37.1x | |
| 1501 Shanghai INT Medical Instruments | HK$40.00 | 9.1% +HK$699.6m | 53.8% | PE35.4x |